Skip to main content

WELLS FARGO & COMPANY/MN

Position in MYGN — Myriad Genetics Inc

CIK 72971 SAN FRANCISCO, CA

Position in MYGN

as of Mar 31, 2026 · filed May 11, 2026
Position Value
$2,263,189
-$424,568 QoQ
Shares Held
502,931
+15.1% QoQ
Ownership
0.532%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 96% Shared 0% None 4%

Common Shares in MYGN Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

WELLS FARGO & COMPANY/MN holds $2,066,225,613 across 37 Diagnostics & Research names. MYGN ranks #21 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in MYGN

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $2,263,189 502,931
2025-12-31 $2,687,757 437,034
2025-09-30 $3,674,559 508,238
2025-06-30 $2,276,720 428,761
2025-03-31 $2,118,243 238,810
2024-12-31 $2,935,679 214,127
2024-09-30 $3,463,957 126,468
2024-06-30 $3,216,317 131,493
2024-03-31 $2,883,762 135,261
2023-12-31 $3,371,471 176,148
2023-09-30 $4,678,207 291,659
2023-06-30 $7,032,902 303,404
2023-03-31 $7,116,462 306,348
2022-12-31 $3,522,735 242,780
2022-09-30 $6,772,539 354,955
2022-06-30 $6,503,786 357,941
2022-03-31 $10,117,596 401,492
2021-12-31 $9,556,001 346,232
2021-09-30 $13,790,799 427,092
2021-06-30 $13,202,667 431,742
2021-03-31 $15,693,777 515,395
2020-12-31 $10,769,389 544,734
2020-09-30 $7,332,194 562,285
2020-06-30 $6,235,421 549,861
2020-03-31 $5,597,226 391,141